联系我们 Contact
搜索 Search
你的位置:首页 > 新闻动态 > 公司新闻

To stop COVID-19 spread, vaccine airplane charter starts

12/8/2020 12:12:04 AM 点击:331
 

On the evening of December 6, 2020, after intensive testing, customs declaration, security check and loading to airplane, the Indonesian government purchased 1.2 million vaccine worth US$18 million, departed from Beijing airport China and arrived at Jakarta Airport safely same day.

Since August 2020, the Indonesian government has been conducting pre-clinical tests in Bandung, West Java. This charter flight prepares for large-scale population vaccination and prevents spread of COVID-19. The charter flight project was launched in early December, following is the specific transportation process,

All vaccines in cold-chained sent from factory to Air China Cargo Terminal at Beijing Capital International Airport at 3AM, December 5. Operation completed at 5AM, customs clearance released in the same morning. Then 24 hours stay in airport per security check request. After that envirotainer loaded into plane in the noon of Dec 6, the plane took off at 15:33 and arrived at Indonesian Jakarta airport that evening.

Departure Airport and Cargo Terminal: Beijing Capital International Airport Air China Cargo Terminal, China
Arrival Airport: Soekarno-Hatta International Airport, Jakarta, Indonesia
Carrier: Garuda Indonesia
Departure Date: December 6, 2020
Time: 7.5 hours non-stop flight
Shipper: Beijing SINOV?? BIOTECH CO.,LTD
Consignee: Government of Indonesia
Shipping quantity: 1.2 million doses

After customs clearance, it will be handed over to the Indonesian government. Vaccination will be launched on a large scale after approval by the Food and Drug Administration. Follow-up plans will be sent to Brazil, Turkey, Pakistan, Russia, Egypt, UAE, Jordan, Peru, Argentina, Mexico and so on from Year 2020 to 2022.

Chinese supply companies include Sinopharm, SINOVAC BIOTECH, cansinotech, zflongkema…

Remarks: Part of the data comes from public network information, estimates, etc. If there is any discrepancy, please contact.